Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

206
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
206
Nature and Nurture01:10

Nature and Nurture

22.1K
Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.1K
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

6.1K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.1K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

177
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
177
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

156
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
156

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Understanding Medication Adherence and Glycaemic Level in People With Type 2 Diabetes Across Countries: A Cross-Sectional and Longitudinal Analysis of Medication Beliefs, Illness Perceptions, Resistance to Illness and Mood.

Endocrinology, diabetes & metabolism·2026
Same author

Selection of Behavior Change Techniques for Asthma Medication Adherence Apps: Evidence-Based Design Study.

JMIR mHealth and uHealth·2025
Same author

Employing illness perceptions and mindsets in health contexts: towards an integrative framework.

Health psychology review·2025
Same author

Adrenal causes of endocrine hypertension in childhood or adolescence.

Journal of endocrinological investigation·2025
Same author

A validation study of the Intentional Nonadherence Scale among people with type 2 diabetes in the United Kingdom.

Diabetic medicine : a journal of the British Diabetic Association·2025
Same author

Best fit framework synthesis of qualitative studies on factors associated with medication nonadherence in people with type 2 diabetes using the COM-B model.

British journal of clinical pharmacology·2025

Related Experiment Video

Updated: Jan 3, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.9K

Managing Paediatric Growth Disorders: Integrating Technology Into a Personalised Approach

Jenny Child1, Christine Davies2, Katie Frost3

  • 1The Child Growth Foundation, Sutton Coldfield, UK

Journal of Clinical Research in Pediatric Endocrinology
|November 21, 2019
PubMed
Summary

Managing growth hormone (GH) therapy requires strong patient-provider relationships and adherence. Digital tools and motivational interviewing can improve adherence and optimize growth outcomes for children.

Keywords:
Growthgrowth hormoneadherencemotivational interviewinge-Health

More Related Videos

Measuring the Functional Abilities of Children Aged 3-6 Years Old with Observational Methods and Computer Tools
11:29

Measuring the Functional Abilities of Children Aged 3-6 Years Old with Observational Methods and Computer Tools

Published on: June 20, 2020

9.6K
Quantified Assessment of Infant's Gross Motor Abilities Using a Multisensor Wearable
09:24

Quantified Assessment of Infant's Gross Motor Abilities Using a Multisensor Wearable

Published on: May 17, 2024

2.0K

Related Experiment Videos

Last Updated: Jan 3, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.9K
Measuring the Functional Abilities of Children Aged 3-6 Years Old with Observational Methods and Computer Tools
11:29

Measuring the Functional Abilities of Children Aged 3-6 Years Old with Observational Methods and Computer Tools

Published on: June 20, 2020

9.6K
Quantified Assessment of Infant's Gross Motor Abilities Using a Multisensor Wearable
09:24

Quantified Assessment of Infant's Gross Motor Abilities Using a Multisensor Wearable

Published on: May 17, 2024

2.0K

Area of Science:

  • Pediatric endocrinology
  • Growth disorders management
  • Patient adherence strategies

Background:

  • Long-term growth management presents challenges for patients, families, and healthcare professionals (HCPs).
  • Personalized growth hormone (GH) therapy response relies on a strong patient-family-HCP relationship.
  • Unmet needs in growth management include identifying and managing poor growth response.

Purpose of the Study:

  • To discuss current unmet needs in growth management.
  • To emphasize the importance of adherence to GH therapy.
  • To explore the role of digital tools and psychological techniques in improving adherence and outcomes.

Main Methods:

  • Review of current challenges in growth management.
  • Discussion of identification and management of poor growth response.
  • Exploration of digital tools for adherence monitoring.
  • Application of psychological techniques like motivational interviewing.

Main Results:

  • Poor growth response likelihood and its management are key concerns.
  • Digital tools can record injections and communicate adherence data.
  • Psychological barriers to adherence can be addressed with specific techniques.
  • Motivational interviewing enhances HCP-patient relationships and improves outcomes.

Conclusions:

  • Personalized care, utilizing psychological skills by HCPs, is crucial for preventing and managing poor adherence.
  • A human-eHealth partnership is essential to maximize the benefits of digital tools for successful growth management.
  • Improving adherence through enhanced relationships and technology is vital for optimizing growth outcomes.